Press Releases

Press Releases

February 28, 2023
CytomX Therapeutics to Present at Upcoming March Investor Conferences
SOUTH SAN FRANCISCO, Calif. , Feb. 28, 2023 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated, localized biologics, today announced that Sean McCarthy , D.Phil ., chief executive officer and chairman, will participate in the following
Additional Formats
Displaying 11 - 18 of 18